MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast Cancer
NCT00462696
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Neoadjuvant chemotherapy
Sponsor
Institut Bergonié